Eu2P is launching a new Talks In Practice workshop event!
Meet the Eu2P faculty experts who will share updated thoughts and practices in key areas and hot topics of drug safety!
Bordeaux, France, 14 September 2018 – The Eu2P programme in pharmacovigilance and pharmacoepidemiology has officially launched a new Talks In Practice event
The Eu2P Talks In Practice consist of a mix of an informal discussion and a workshop in different key and hot topics of pharmacovigilance and pharmacoepidemiology.
The full event is taking place during two days but can be attended on a one day only basis.
This year, the following topics are covered:
- SEP 27, 2018
- Role of the QPPV and the evolution of the PSMF
- The New EudraVigilance System – Where are we now?
- Signal detection
- RMP: the effects of inappropriate use of the target medicine
- Risk Management
- SEP 28, 2018
- Selecting outcomes: surrogate endpoints
- Real World Evidence, measures, implications and impact on decision making
- Pharmacoepidemiology in practice
Eu2P FACULTY: Dr Antònia Agustí (Universitat Autònoma de Barcelona), Pr Bernard Bégaud (Université de Bordeaux), Kiki Cheung (Erasmus MC), Pr Albert Figueras (Universitat Autònoma de Barcelona), Vijay Kara (QPPV Office Director at GSK), Pr Olaf Klungel (Utrecht Universiteit), Pr Bruno Stricker (Erasmus MC)
This event is free for the new Eu2P online Master students.
More info on the Eu2P Talks In Practice page.
Eu2P is a European online education and training programme in pharmacovigilance and pharmacoepidemiology created by a consortium of 7 Universities, the European and French regulatory agencies and 15 members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the financial support provided by the Innovative Medicines Initiatives (IMI JU).
Dr. Karine Palin
Eu2P Programme Manager
+33 (0) 557 579 257
Eu2P Central Office,
Université de Bordeaux
146 rue Léo Saignat, Case 36
33076 Bordeaux cedex France